Cardiosense

About

Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease.

Chicago,Illinois,United States
11 - 50
https://www.cardiosense.com

Highlights

Details

Last Funding Type: Series A
Last Funding Money Raised: $15.10M
Industries: Artificial Intelligence,Health Care,Machine Learning,Predictive Analytics,Wearables
Founded date: May 1, 2020
Number Of Employee: 11 - 50
Operating Status: Active

Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

$15.10M

Cardiosense has raised a total of $15.10M in funding over 2 rounds. Their latest funding was raised on Dec 8, 2022 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 8, 2022	Series A	$15.10M	6	Broadview Ventures Hatteras Venture Partners	—	Detail

Investments

Number of Investments

Number of Lead Investments

6

0

Cardiosense has made 6 investments. Their most recent investment was on Jul 28, 2020, when Everphone raised €34M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Jul 28, 2020 Everphone	Series B	€34M	B2B	—
Mar 3, 2020 Zumper	Series D	$61.75M	B2B	—
Oct 2, 2019 Impala	Series A	$11M	Developer APIs	—
Apr 24, 2018 Impala	Seed	$1.75M	Developer APIs	—
May 19, 2016 Zenly	Series A	€11.20M	Android	—

Investors

Number of Lead Investors

Number of Investors

2

6

Cardiosense is funded by 6 investors. Broadview Ventures and Hatteras Venture Partners are the most recent investors.

Investor Name	Lead Investor	Funding Round
Broadview Ventures	Yes	Series A
Hatteras Venture Partners	Yes	Series A
Laerdal Million Lives Fund	—	Series A
OSF Ventures	—	Series A
Portal Innovations	—	Series A
UnityPoint Health Ventures	—	Series A